מאמרים עם הרשאות לגישה ציבורית - Paul R Yarnold, Ph.D.למידע נוסף
ללא העלאה: 2
Improving oncology biosimilar launches in the EU, the USA, and Japan: an updated Policy Review from the Southern Network on Adverse Reactions
CL Bennett, MW Schoen, S Hoque, BJ Witherspoon, DM Aboulafia, ...
The Lancet Oncology 21 (12), e575-e588, 2020
הרשאות: US National Institutes of Health
מחברים אחראים: CL Bennett
Reporting of serious adverse events during cancer clinical trials to the institutional review board: an evaluation by the research on adverse drug events and reports (RADAR …
SM Belknap, CH Georgopoulos, J Lagman, SA Weitzman, L Qualkenbush, ...
The Journal of Clinical Pharmacology 53 (12), 1334-1340, 2013
הרשאות: US National Institutes of Health
מחברים אחראים: SM Belknap
זמינים באתר כלשהו: 27
Ticlopidine-and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989–2008)
A Zakarija, HC Kwaan, JL Moake, N Bandarenko, DK Pandey, JM McKoy, ...
Kidney International 75, S20-S24, 2009
הרשאות: US National Institutes of Health
Touch, Caring, and Cancer: randomized controlled trial of a multimedia caregiver education program
W Collinge, J Kahn, T Walton, L Kozak, S Bauer-Wu, K Fletcher, ...
Supportive Care in Cancer 21, 1405-1414, 2013
הרשאות: US National Institutes of Health
Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride
T Kiguradze, WH Temps, PR Yarnold, J Cashy, RE Brannigan, B Nardone, ...
PeerJ 5, e3020, 2017
הרשאות: US National Institutes of Health
Combining machine learning and matching techniques to improve causal inference in program evaluation
A Linden, PR Yarnold
Journal of evaluation in clinical practice 22 (6), 868-874, 2016
הרשאות: US National Institutes of Health
Adverse event reporting in clinical trials of finasteride for androgenic alopecia: a meta-analysis
SM Belknap, I Aslam, T Kiguradze, WH Temps, PR Yarnold, J Cashy, ...
JAMA dermatology 151 (6), 600-606, 2015
הרשאות: US National Institutes of Health
Using classification tree analysis to generate propensity score weights
A Linden, PR Yarnold
Journal of Evaluation in Clinical Practice 23 (4), 703-712, 2017
הרשאות: US National Institutes of Health
Using machine learning to model dose–response relationships
A Linden, PR Yarnold, BK Nallamothu
Journal of Evaluation in Clinical Practice 22 (6), 860-867, 2016
הרשאות: US National Institutes of Health
Evaluation of a potential clinical interaction between ceftriaxone and calcium
E Steadman, DW Raisch, CL Bennett, JS Esterly, T Becker, M Postelnick, ...
Antimicrobial agents and chemotherapy 54 (4), 1534-1540, 2010
הרשאות: US National Institutes of Health
Hepatotoxicity associated with long-versus short-course HIV-prophylactic nevirapine use: a systematic review and meta-analysis from the Research on Adverse Drug events And …
JM McKoy, CL Bennett, MH Scheetz, V Differding, KL Chandler, KK Scarsi, ...
Drug safety 32, 147-158, 2009
הרשאות: US National Institutes of Health
Melanoma complicating treatment with natalizumab for multiple sclerosis: A report from the Southern Network on Adverse Reactions (SONAR)
RA Sabol, V Noxon, O Sartor, JR Berger, Z Qureshi, DW Raisch, ...
Cancer medicine 6 (7), 1541-1551, 2017
הרשאות: US National Institutes of Health
Regulatory and clinical experiences with biosimilar filgrastim in the US, the European Union, Japan, and Canada
B Chen, S Nagai, JO Armitage, B Witherspoon, C Nabhan, AC Godwin, ...
The oncologist 24 (4), 537-548, 2019
הרשאות: US National Institutes of Health
Fibromyalgia symptom reduction by online behavioral self-monitoring, longitudinal single subject analysis and automated delivery of individualized guidance
W Collinge, P Yarnold, R Soltysik
North American journal of medical sciences 5 (9), 546, 2013
הרשאות: US National Institutes of Health
Machine learning to stratify methicillin-resistant staphylococcus aureus risk among hospitalized patients with community-acquired pneumonia
NJ Rhodes, R Rohani, PR Yarnold, AE Pawlowski, M Malczynski, C Qi, ...
Antimicrobial agents and chemotherapy 67 (1), e01023-22, 2023
הרשאות: US National Institutes of Health
End of an era for erythropoiesis‐stimulating agents in oncology
MW Schoen, S Hoque, BJ Witherspoon, B Schooley, O Sartor, YT Yang, ...
International journal of cancer 146 (10), 2829-2835, 2020
הרשאות: US National Institutes of Health
Caveat Medicus: Clinician experiences in publishing reports of serious oncology-associated adverse drug reactions
CL Bennett, B Schooley, MA Taylor, BJ Witherspoon, A Godwin, J Vemula, ...
PloS one 14 (7), e0219521, 2019
הרשאות: US National Institutes of Health, US Department of Veterans Affairs
Consequences to patients, clinicians, and manufacturers when very serious adverse drug reactions are identified (1997–2019): A qualitative analysis from the Southern Network on …
CL Bennett, S Hoque, N Olivieri, MA Taylor, D Aboulafia, C Lubaczewski, ...
EClinicalMedicine 31, 2021
הרשאות: US National Institutes of Health, US Department of Veterans Affairs
End of an era of administering erythropoiesis stimulating agents among Veterans Administration cancer patients with chemotherapy-induced anemia
S Hoque, BJ Chen, MW Schoen, KR Carson, J Keller, BJ Witherspoon, ...
PloS one 15 (6), e0234541, 2020
הרשאות: US National Institutes of Health, US Department of Veterans Affairs
Characterizing risk factors for Clostridioides difficile infection among hospitalized patients with community-acquired pneumonia
NJ Rhodes, CC Jozefczyk, WJ Moore, PR Yarnold, K Harkabuz, ...
Antimicrobial agents and chemotherapy 65 (7), 10.1128/aac. 00417-21, 2021
הרשאות: US National Institutes of Health
המידע על הפרסום ועל הגורמים המממנים נקבע באופן אוטומטי על ידי תוכנת מחשב